Corticotrofina e cortiomdes em neurologia: avaliação critica dos resultados em 518 pacientes hospitalizados

Assis, J. Lamartine de; Tetner, Jayme

doi:10.1590/S0004-282X1968000400001

Resumos

Com base no tratamento pela corticotrofina e corticóides de 518 pacientes internados no período de 1952 e 1967, os autores fazem a avaliação crítica dos resultados dessa terapêutica em diversas afecções do sistema nervoso. São as seguintes as afecções estudadas: moléstias desmielinizantes, polirradiculoneurite ,coréia aguda, mielose funicular, hipsarritmia, miastenia grave, polimiosite, neurotuberculose e neurocisticercose. Os medicamentos empregados foram o ACTH ou corticotrofina pelas vias venosa ou intramuscular, e a cortisona e derivados pelas vias oral ou parenteral. O uso de derivados da cortisona, especialmente o acetato de metilprednisolona, pela via intratecal constituirá objeto de outro estudo. Os resultados do tratamento hormonal foram analisados sob os aspectos curativo e preventivo. Neste último aspecto a análise se restringiu à prevenção de seqüelas nos casos de neurotuberculose e neurocisticercose. A avaliação dos efeitos terapêuticos obedeceu a critério clínico e, quando necessário, ficou subordinada ao estudo evolutivo dos exames complementares. Foram referidos apenas os resultados imediatos, observados pela condição de alta dos pacientes. Desse estudo os autores concluem: 1. A corticotrofina e/ou corticóides são empregados com resultados favoráveis no tratamento de diversas moléstias do sistema nervoso, tanto como terapêutica curativa como preventiva. 2. Os resultados em geral são de avaliação difícil e estão na dependência da natureza e caráter evolutivo da afecção e da época em que o tratamento é instituído relativamente ao início da sintomatologia. 3. Em relação ao tratamento curativo, as afecções agudas de natureza imunalérgica ou os surtos das neuropatías de evolução cíclica e as suscetíveis de agravação progressiva com manifestações paroxísticas foram as que melhor responderam à terapêutica hormonal. Certas moléstias que costumam evoluir com fases de agravação e cuja natureza parece estar ligada a fatores imunológicos, também responderam de modo favorável ao emprego do ACTH e/ou corticóides. 4. Conseqüentemente, melhores efeitos foram obtidos na coréia aguda, polirradiculoneurite, complicações neurológicas das vacinações, da coqueluche, da parotidite epidêmica e de febres eruptivas, nas crises paroxísticas e disritmia cerebral da hipsarritmia e na miastenia grave. Em ordem decrescente quanto aos benefícios proporcionados pela terapêutica hormonal, estão a esclerose múltipla e outras desmielinizações primárias. O número pequeno de casos não permitiu conclusão quanto à polimiosite. É de notar que, em relação às desmielinizações primárias, os melhores resultados foram obtidos quando o tratamento era aplicado no combate aos primeiros surtos de agravação da moléstia tornando-se menos eficiente nos surtos ulteriores. A mielose funicular foi a neuropatía que menos se beneficiou com o emprego isolado dos glicocorticóides. 5. Na meningencefalite tuberculosa subaguda ou crônica os resultados em geral não foram bons, porém nos casos recentes a associação da medicação específica ao ACTH ou corticóides, foi benéfica, tanto como terapêutica curativa como na prevenção de aderências pia-aracnóideas. 6. Na neurocisticercose os resultados de modo geral foram favoráveis, justificando amplamente o emprego dos hormônios glicocorticóides como terapêutica preventiva no sentido de limitar a formação de aderências. Usados com critério e com as necessárias precauções, o ACTH e os corticóides acarretaram índice significativamente baixo de complicações que, no entanto, foram quase sempre muito graves. 8. Com essas restrições a terapêutica hormonal constitui arma preciosa no arsenal terapêutico da Neurologia. Mesmo nos casos menos favoráveis, freqüentemente esses hormônios representam o único recurso disponível e o pouco que se obtiver será suficiente para justificar o seu emprego. Em certos casos de evolução dramática o uso do ACTH e/ou corticóides torna-se quase imperativo.

Based on the treatment with corticotrofin and corticosteroids of 518 patients admited at the "Clínica Neurológica do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo", in the period of 1952 to 1967, the authors performed a critical evaluation of the results obtained in several diseases of the nervous system: demyelinating diseases, polyradiculitis (Landry-Guillain-Barré syndrome), Sydenham's chorea, sabacute combined degeneration, hypsarrhytmia, myasthenia gravis, polymiositis, tuberculous meningitis and neurocysticercosis. ACTH or corticotrofin were employed intravenously or intramuscularly and the steroids were given orally or parenterally. The results with adrenal steroids or ACTH treatment were analysed under the treatment and preventive aspects. Concerning this aspect the analysis hás been limited, to tuberculous meningitis and neurocistycercosis cases. The evaluation of the therapeutic effects was based on clinical criterion and, when necessary, has been subordinated to an evolutive study concerning complementary examinations. Only immediate results based on general conditions of the patients at hospitalar discharge were reported. The authors conclude: 1. The corticotrofin and/or corticosteroids are used with favorable results in the treatment of several nervous system diseases as a therapeutic method as well as prophylactically. 2. Generally the results are difficult to evaluate and some times they depend on the nature and evolution of the disease and also on the period in which the treatment was established. 3. Regarding the therapeutic methods, the acute immunoallergic diseases or neuropathies with cyclical evolution those with a tendency to a progressive worsening and those with paroxystic manifestations responded in a better way to hormonal therapy. Some diseases which use to have an evolution with exacerbations and whose nature seems to be related to immunological factors also responded in a favorable way to ACTH and/or corticosteroids. 4. Consequently, better results were obtained in Sydenham's chorea, polyradiculitis, neurological complications of vaccination, in whooping-cough, epidemic parotiditis and eruptive fevers, in paroxysm crisis and cerebral dysrhytmia of hypsarrhytmia and in myasthenia gravis. In decreasing order regarding hormonal therapeutic benefits the authors point out multiple sclerosis and other primary demyelinating diseases. The small number of cases has not allowed a definite conclusion regarding polymiositis. Concerning primary demyelinating diseases the best results have been obtained when the treatment was employed during the first acute demyelinizating period of the disease, becoming less efficient on further exacerbations. Subacute combined degenation has been the neuropathy with less benefits regarding the hormonal treatment. 5. In sub-acute or chronic meningitis there were no good apparent results, but in recent cases in which the specific medication has been associated to ACTH or corticosteroids the effect has been excellent. 6. In neurocysticercosis the results generally have been favorable, justifying extensive use of hormones as preventive therapeutic in this disease. 7. With a criterious use and necessary precaution ACTH and corticosteroids have a significative low incidence of complications that, however, have been always severe. 8. With those restrictions, the treatment by hormones constitutes a precious weapon in neurological therapy. Even in those unfavorable cases, frequently the hormones represent the only available method and even the minor results obtained will justify its use. In some cases of dramatic evolution the use of ACTH and/or corticosteroids becomes almost imperative.

Corticotrofina e cortiomdes em neurologia. Avaliação critica dos resultados em 518 pacientes hospitalizados

Corticotropin and corticosteroids in Neurology. Critical evaluation of the results in 518 patients

J. Lamartine de Assis^I; Jayme Tetner^II

^IDocente-Livre; Clinica Neurológica do Hospital das Clínicas da FMUSP (Prof. Adherbal Tolosa)

^IIMédico-adido; Trabalho da Clinica Neurológica do Hospital das Clínicas da FMUSP (Prof. Adherbal Tolosa)

RESUMO

Com base no tratamento pela corticotrofina e corticóides de 518 pacientes internados no período de 1952 e 1967, os autores fazem a avaliação crítica dos resultados dessa terapêutica em diversas afecções do sistema nervoso.

São as seguintes as afecções estudadas: moléstias desmielinizantes, polirradiculoneurite ,coréia aguda, mielose funicular, hipsarritmia, miastenia grave, polimiosite, neurotuberculose e neurocisticercose.

Os medicamentos empregados foram o ACTH ou corticotrofina pelas vias venosa ou intramuscular, e a cortisona e derivados pelas vias oral ou parenteral. O uso de derivados da cortisona, especialmente o acetato de metilprednisolona, pela via intratecal constituirá objeto de outro estudo.

Os resultados do tratamento hormonal foram analisados sob os aspectos curativo e preventivo. Neste último aspecto a análise se restringiu à prevenção de seqüelas nos casos de neurotuberculose e neurocisticercose.

A avaliação dos efeitos terapêuticos obedeceu a critério clínico e, quando necessário, ficou subordinada ao estudo evolutivo dos exames complementares. Foram referidos apenas os resultados imediatos, observados pela condição de alta dos pacientes.

Desse estudo os autores concluem:

1. A corticotrofina e/ou corticóides são empregados com resultados favoráveis no tratamento de diversas moléstias do sistema nervoso, tanto como terapêutica curativa como preventiva.

2. Os resultados em geral são de avaliação difícil e estão na dependência da natureza e caráter evolutivo da afecção e da época em que o tratamento é instituído relativamente ao início da sintomatologia.

3. Em relação ao tratamento curativo, as afecções agudas de natureza imunalérgica ou os surtos das neuropatías de evolução cíclica e as suscetíveis de agravação progressiva com manifestações paroxísticas foram as que melhor responderam à terapêutica hormonal. Certas moléstias que costumam evoluir com fases de agravação e cuja natureza parece estar ligada a fatores imunológicos, também responderam de modo favorável ao emprego do ACTH e/ou corticóides.

4. Conseqüentemente, melhores efeitos foram obtidos na coréia aguda, polirradiculoneurite, complicações neurológicas das vacinações, da coqueluche, da parotidite epidêmica e de febres eruptivas, nas crises paroxísticas e disritmia cerebral da hipsarritmia e na miastenia grave. Em ordem decrescente quanto aos benefícios proporcionados pela terapêutica hormonal, estão a esclerose múltipla e outras desmielinizações primárias. O número pequeno de casos não permitiu conclusão quanto à polimiosite. É de notar que, em relação às desmielinizações primárias, os melhores resultados foram obtidos quando o tratamento era aplicado no combate aos primeiros surtos de agravação da moléstia tornando-se menos eficiente nos surtos ulteriores. A mielose funicular foi a neuropatía que menos se beneficiou com o emprego isolado dos glicocorticóides.

5. Na meningencefalite tuberculosa subaguda ou crônica os resultados em geral não foram bons, porém nos casos recentes a associação da medicação específica ao ACTH ou corticóides, foi benéfica, tanto como terapêutica curativa como na prevenção de aderências pia-aracnóideas.

6. Na neurocisticercose os resultados de modo geral foram favoráveis, justificando amplamente o emprego dos hormônios glicocorticóides como terapêutica preventiva no sentido de limitar a formação de aderências.

Usados com critério e com as necessárias precauções, o ACTH e os corticóides acarretaram índice significativamente baixo de complicações que, no entanto, foram quase sempre muito graves.

8. Com essas restrições a terapêutica hormonal constitui arma preciosa no arsenal terapêutico da Neurologia. Mesmo nos casos menos favoráveis, freqüentemente esses hormônios representam o único recurso disponível e o pouco que se obtiver será suficiente para justificar o seu emprego. Em certos casos de evolução dramática o uso do ACTH e/ou corticóides torna-se quase imperativo.

SUMMARY

Based on the treatment with corticotrofin and corticosteroids of 518 patients admited at the "Clínica Neurológica do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo", in the period of 1952 to 1967, the authors performed a critical evaluation of the results obtained in several diseases of the nervous system: demyelinating diseases, polyradiculitis (Landry-Guillain-Barré syndrome), Sydenham's chorea, sabacute combined degeneration, hypsarrhytmia, myasthenia gravis, polymiositis, tuberculous meningitis and neurocysticercosis. ACTH or corticotrofin were employed intravenously or intramuscularly and the steroids were given orally or parenterally.

The results with adrenal steroids or ACTH treatment were analysed under the treatment and preventive aspects. Concerning this aspect the analysis hás been limited, to tuberculous meningitis and neurocistycercosis cases.

The evaluation of the therapeutic effects was based on clinical criterion and, when necessary, has been subordinated to an evolutive study concerning complementary examinations. Only immediate results based on general conditions of the patients at hospitalar discharge were reported.

The authors conclude:

1. The corticotrofin and/or corticosteroids are used with favorable results in the treatment of several nervous system diseases as a therapeutic method as well as prophylactically.

2. Generally the results are difficult to evaluate and some times they depend on the nature and evolution of the disease and also on the period in which the treatment was established.

3. Regarding the therapeutic methods, the acute immunoallergic diseases or neuropathies with cyclical evolution those with a tendency to a progressive worsening and those with paroxystic manifestations responded in a better way to hormonal therapy. Some diseases which use to have an evolution with exacerbations and whose nature seems to be related to immunological factors also responded in a favorable way to ACTH and/or corticosteroids.

4. Consequently, better results were obtained in Sydenham's chorea, polyradiculitis, neurological complications of vaccination, in whooping-cough, epidemic parotiditis and eruptive fevers, in paroxysm crisis and cerebral dysrhytmia of hypsarrhytmia and in myasthenia gravis. In decreasing order regarding hormonal therapeutic benefits the authors point out multiple sclerosis and other primary demyelinating diseases. The small number of cases has not allowed a definite conclusion regarding polymiositis. Concerning primary demyelinating diseases the best results have been obtained when the treatment was employed during the first acute demyelinizating period of the disease, becoming less efficient on further exacerbations. Subacute combined degenation has been the neuropathy with less benefits regarding the hormonal treatment.

5. In sub-acute or chronic meningitis there were no good apparent results, but in recent cases in which the specific medication has been associated to ACTH or corticosteroids the effect has been excellent.

6. In neurocysticercosis the results generally have been favorable, justifying extensive use of hormones as preventive therapeutic in this disease.

7. With a criterious use and necessary precaution ACTH and corticosteroids have a significative low incidence of complications that, however, have been always severe.

8. With those restrictions, the treatment by hormones constitutes a precious weapon in neurological therapy. Even in those unfavorable cases, frequently the hormones represent the only available method and even the minor results obtained will justify its use. In some cases of dramatic evolution the use of ACTH and/or corticosteroids becomes almost imperative.

Texto completo disponível apenas em PDF.

Full text available only in PDF format.

Clinica Neurológica Faculdade de Medicina da Universidade de São Paulo Caixa Postal 3461 São Paulo, SP Brasil.

Trabalho da Clinica Neurológica do Hospital das Clínicas da FMUSP (Prof. Adherbal Tolosa), apresentado ao III Congresso Brasileiro de Neurologia (Recife, PE 14 a 18 de julho de 1968)

Referências bibliográficas

1. AINGER, L. E.; ELY, R. S.; DONE, A. K. & KELLY, V. C. Sydenham's chorea. Effects of hormonetherapy. Amer. J. Dis. Child. 89:580-590, 1955.
2. ALAJOUANINE, Th.; CASTAIGNE, P. & LHERMITTE, F. A propos du traitement de la esclérose en plaques par la cortisone. Rev. neurol. (Paris) 94:352, 1956.
3. ALBERNAZ, J. G. & CARMO, R. J. Terapęutica hormonal na coréia de Sydenham. Arq. Neuro-Psiquiat. (Săo Paulo) 15:204-210, 1957.
4. ALEXANDER, L.; CASS, L. J.; ENDERS, M. & SARAI, K. Adrenocortical response to high dosage ACTH therapy in patients with multiple sclerosis. Confin. neurol. (Basel) 28:1-17, 1966.
5. ALEXANDER, L.; BERKELEY, A. W. & ALEXANDER, A. M. Prognosis and treatment of multiple sclerosis Quantitative nosometric study. J. Amer. med. Ass. 166:1943-1949, 1958.
6. ALEXANDER, L. & CASS, L. J. The present status of ACTH Therapy in multiple sclerosis. Ann. intern. Med. 58:454-471, 1963.
7. ALLEN, J. E. Treatment of measles encephalitis with adrenal steroids. Pediatrics 20:87-91, 1957.
8. ARONSON, N.; DOUGLAS, H. S. & LEWIS, J. M. Cortisone in Sydenham's chorea: report of 2 cases. J. Amer. med. Ass. 145:30-33, 1951.
9. ARROBA, C. V. Tratamientos de la miastenia gravis. Rev. clin. esp. 82: 195-199, 1961.
10. ASHBY, M. & GRANT, H. Tuberculous meningitis treated with cortisone. Lancet 1:65-66, 1955.
11. ASSIS, J. L. Síndrome de Guillain-Barré. A propósito de tręs casos, sendo um tratado pelo ACTH. Arq. Neuro-Psiquiat. (Săo Paulo) 10:133-134, 1952.
12. ASSIS, J. L. Encefalopatía reumática tratada pelo ACTH e cortisona. Rev. paulista Med. 44:322-326, 1954.
13. ASSIS, J. L. A terapęutica química e biológica atual da meningocefalite tuberculosa difusa. Rev. paulista Med. 48:80-89, 1956.
14. ASSIS, J. L. Tratamento dos casos graves de miastenia. Açăo do ACTH e cortisona. Consideraçőes a propósito de tręs casos. Arq. Neuro-Psiquiat. (Săo Paulo) 14:28-36, 1956.
15. ASSIS, J. L. Tratamento das formas severas de miastenia grave pelo ACTH por via intravenosa. Arq. Neuro-Psiquiat. (Săo Paulo) 18:359-382, 1960.
16. ASSIS, J. L. Tratamento atual da miastenia grave. Rev. paulista Med. 67:231-242, 1965.
17. ASSIS, J. L. Moléstias desmielinizantes. InManual de Clínica Neurológica, H. Canelas, editor. Sarvier, Săo Paulo, 1967, pp. 105-117.
18. ASSIS, J. L. Neurotuberculose. InManual de Clínica Neurológica, H. M. Canelas, editor. Sarvier, Săo Paulo, 1967, pp. 229-236.
19. ASSIS, J. L. Miastenia grave. InManual de Clínica Neurológica, H. M. Canelas, editor. Sarvier, Săo Paulo, 1967, pp. 339-347.
20. ASSIS, J. L. & SPINA-FRANÇA, A. Síndrome de Güillain-Barré. A propósito de cinco casos tratados com ACTH e cortisona. Arq. Neuro-Psiquiat. (Săo Paulo) 11:414-419, 1953.
21. ASSIS, J. L. & DUCHĘNE, G. H. Complicaçőes neurológicas da vacinaçăo anti-rábica. Arq. Neuro-Psiquiat. (Săo Paulo) 17:235-250, 1959.
22. AUSTIN, J. H. Recurrent polyneuropathies and their corticosteroid treatment with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 81:157-192, 1958.
23. BAMMER, H. ACTH und Corticoidbehandlung neurologischer Krankheiten. Dtsch. Z. Nervenheilk. 185:121-149, 1963.
24. BASTRUP-MADSEN, P. Non-anaemic neuropathy due to deficiency of anti-pernicious anaemia principle. Acta psychiat. neurol. scand. Supl. 108:45-36, 1956.
25. BARNICK, D. D. & WALTON, J. M. Polymiositis. Amer. J. Med. 35: 646-660, 1963.
26. BAUMANN, J. Results of treatment of certain diseases of the central nervous system with ACTH and corticosteroids. Acta neurol. scand. Supl. 13:453-461, 1965.
27. BERG, J. M. Complications neurologiques de la coqueluche. Wld Neurol. 2:56-65, 1961.
28. BERLACHER, F. J. & ALBINGTON, R. B. ACTH and cortisone in Guillain-Barré syndrome: review of the literature and report of a treated case following primary atypical pneumonia. Ann. intern. Med. 48:1106-1118, 1958.
29. BLOMBERG. L. H. Comments on treatment of multiple sclerosis with ACTH. Acta neurol. scand. Supl. 13:485-487, 1965.
30. BLOOD, A.; LOCKE, W. & CARAHASI, R. Guillain-Barré syndrome treated with corticotropin (ACTH). J. Amer. med. Ass. 152:139-140, 1953.
31. BOGAERT, L. van; RADERMECKER, M. A.; LOWENTHAL, A. & KETELAER, C. J. Les polymyosites chroniques (Essais avec la cortisone). Acta neurol. psychiat. belg. 55:869-922, 1965.
32. BOWER, B. D. & JEAVONS. P. M. Infantile spasms and hypsarrhythmia. Lancet 1:605-609, 1959.
33. BRANDRIN, M. W.; SMITH, J. W. & FRIEDMAN, R. M. Supression of experimental allergic encephalomyelitis by antimetabolites. Ann. N. Y. Acad. Sci. 122:356-368, 1965.
34. BRIGGS, G. W. & BROWN, W. M. Neurological complications of antirabies vaccine. Treatment with corticosteroids. J. Amer. med. Ass. 173:802-804, 1960.
35. BROOKS, W. D. W.; FLETCHER, A. P. & WILSON, R. R. Spinal cord complications of tuberculous meningitis. Quart. J. Med. 23:275-290, 1954.
36. CANELAS, H. M. Distúrbios neurológicos nos estados carenciais aqúilicos, Arq. Neuro-Psiquiat. (Săo Paulo) 10:1-40, 1952.
37. CANELAS, H. M. Mieloses funiculares: consideraçőes a propósito de 110 casos. Arq. Neuro-Psiquiat. (Săo Paulo) 18:105-132, 1960.
38. CANELAS. H. M. Corticotrofina e corticosteróides em Neurologia. Rev. paulista Med. 57:301-313, 1960.
39. CANELAS, H. M. Neurocisticercose: incidęncia, diagnóstico e formas clínicas. Arq. Neuro-Psiquiat. (Săo Paulo) 20:1-16, 1962.
40. CANELAS, H. M. & LEVY, J. A. Resultados preliminares do emprego do ACTH nas degeneraçőes combinadas da medula. Arq. Neuro-Psiquiat. (Săo Paulo) 11:253-258, 1953.
41. CANELAS, H. M. & SPINA-FRANÇA, A. ACTH e cortisona em Neurologia. Resultados em 23 casos. Rev. paulista Med. 43:115-120, 1953.
42. CANELAS, H. M.; CARVALHO, N. & ROCHA, A. G. Effect of corticotropin on the absorption of vitamina B¹² in sub-acute combined degeneration of the spinal cord. Arq. Neuro-Psiquiat. (Săo Paulo) 23:75-81, 1965.
43. CASS, L. J.; ALEXANDER, L. & ENDERS, M. Complications of corticotropin therapy in multiple sclerosis. J. Amer. med. Ass. 197:173-210, 1966.
44. CLARKE, E.; BAYLISS, R. I. S. & COOPER, R. Landry-Guillain-Barré syndrome: cardiovascular complications. Treatment with ACTH and cortisone. Brit. med. J. 2:1504-1507, 1954.
45. CROZIER, R. E. & AINLEY, A. B. The Guillain-Barré syndrome. New Engl. J. Med. 252:83-88, 1955.
46. CUNNINGHAM, V. R. & FIELD, E. J. Experimental allergic encephalomyelitis: protection experiments with encephalitogenic factor and tubercle fraction. Ann. N. Y. Acad. Sci. 122:346-355, 1965.
47. DANILSEN, J. Infantile spasms and hypsarhythmia treated with corticosteroids. Acta neurol. scand. Supl. 13:489-492, 1965.
48. DE JONG, R. N. The Guillain-Barré syndrome. Polyradiculoneuritis with albuminocytologic dissociation. Arch. Neurol. Psychiat. (Chicago) 44:1044-1068, 1940.
49. DESTAIGNE, F. La corticothérapie dans les maladies infectieuses. Rev. méd. Dijon 2:251-256, 1967.
50. DIESSNER, G. R. & WINKELMANN, R. K. Treatment of polymyositis. Mod. Treatment 3:304-312, 1966.
51. DOBBS, J. M.; CLEMENTS, J. D. & BAIRD, H. W. Treatment of infantile myoclonic seizures with corticotropin and corticosteroid. Amer. J. Dis. Child. 98:524-525, 1959.
52. DOERNER, A. A.; NAEGELE, C. F. & REGAN, F. D. Development of tuberculous meningitis following cortisone therapy. Amer. Rev. Tuberc. 64: 564-571. 1951.
53. DRENICK, E. J. & AVOL, M. Two cases of Guillain-Barré syndrome treated with cortisone. Neurology 3:935-938, 1953.
54. EATON, L. M. The perspective of neurology in regard to polymyositis. A study of 41 cases. Neurology 4:245-263, 1954.
55. FELDMAN, S. Clinical observations on the value of adrenocortical therapy in the Guillain-Barré syndrome. Confín, neurol. (Basel) 26:76-88, 1965.
56. FELDMAN, S.; BEHAR, J. A. & SAMUELOFF, M. Effect of cortisone and hydrocortisone on piarachnoid adhesions; experimental study. Arch. Neurol. Psychiat. (Chicago) 74:681-688, 1955.
57. FERRARO, A. Studies on multiple sclerosis. J. Neuropath. 17:278-297, 1958.
58. FERRARO, A. & CAZZULLO, C. L. Chronic experimental allergic encephalomyelitis in monkeys. J. Neuropath. 7:235-260, 1948.
59. FERRARO, A. & JERVIS, G. A. Experimental disseminated encephalopathy in the monkey. Arch. Neurol. Psychiat. (Chicago) 43:195-209, 1940.
60. FERRARO, A. & ROIZIN, L. Experimental allergic encephalomyelitis during and following cortone acetate treatment. J. Neuropath. 12:373-386, 1953.
61. FERRARO, A. & ROIZIN, L. Hyperergic encephalomyelitis following exanthematic diseases, infectious diseases and vaccination. J. Neuropath. 16: 423-445, 1957.
62. FERRARO, A.; ROIZIN, L. & CAZZULLO, C. L. Experimental studies in allergic encephalomyelitis. J. Neuropath. 9:18-28, 1950.
63. FÍESE, M. J.; CHEY, S. & RADDING, J. Guillain-Barré syndrome in infectious mononucleosis. Report of case with recovery following administration of cortisone. Arch, inter. Med. 92:438-441, 1953.
64. FINLAND, M.; KASS, E. H. & INGBAR, S. H. Further observations on the effects of ACTH in acute infections. InProceedings, II ACTH Clin. Conf. Vol. 1. Blakiston, New York, 1950, pág. 478.
65. FISCH, A. M.; OLIVEIRA, C. & FERNANDES, I. Contribuiçăo ao estudo da hipsarritmia. Arq. Neuro-Psiquiat. (Săo Paulo) 24:15-27, 1966.
66. FOG, T. Some experiences with ACTH. Treatment in disseminated sclerosis. Acta endocr. 9:213-257, 1952.
67. FOSTER, J. B. The use of adrenal steroids in diseases of the nervous system. In Modern Trends in Neurology. D. Williams, editor. Butterworths, London, pp. 292-313, 1962.
68. FOT, T. The long-term treatment of multiple sclerosis with corticoids. Acta neurol. scand. Supl. 13:473-484, 1965.
69. FREIDBERG, L. D. The place of corticotropin in the treatment of myastenia gravis. Ann. intern. Med. 52:806-818, 1960.
70. FREUND, J. & McDERMOTT Sensitization to horse serum by means of adjuvants. Proc. Soc. exp. Biol. (New York) 49:548-553, 1942.
71. FREUND, J.; STERN, E. R. & PISANI, T. M. Isoallergic encephalomyelitis and radiculitis in guinea-pigs after one injection of brain and mycobacteria in water-in-oil emulsion. J. Immunol. 57:179-194, 1947.
72. FROST, J. W. & GOLDWEIN, M. I. Observation on vitamina B¹² absorption in primary pernicious anemia during administration of adrenocortical steroids. New Engl. J. Med. 258:1096-1098, 1958.
73. FROST, J. W. GOLDWEIN, M. I. & KAUGMAN, B. D. Studies of B₁₂ Co⁶⁰ absorption in malabsorption syndrome: results before and during specific therapy. Ann intern. Med. 47:293-299, 1957.
74. GAMMON, G. A. & DILWORTH, M. J. Effect of corticotropin on paralysis of experimental allergic encephalomyelitis. Arch. Neurol. Psychiat. (Chicago) 69:649, 1953.
75. GLASER, G. H. Les cortico-stéroides et l'ACTH dans les affections nerveuses. Wld Neurol. 1:12-21, 1960.
76. GLASER, G. H. & MERRITT, H. H. Effects of corticotropin (ACTH) and cortisone on disorders of the nervous system. J. Amer. med. Ass. 148: 898-904, 1952.
77. GLASS, G. B. J. Biochemistry and physiology of Castle's intrinsic factor and its relationship to the metabolism of vitamin B₁₂ Rev. Hémat. 10: 137-179, 1955.
78. GLASS, G. B. J. Intestinal absorption and hepatic uptake of vitamina B_]2in diseases of the gastrointestinal tract. Gastroenterology 30:37-52, 1956.
79. GLASS, G. B. J. Gastric intrinsic factor and its function in the metabolism of vitamin B₁₂ Physiol. Rev. 43:529-849, 1963.
80. GORDIN, R. Vitamin B₁₂ absorption in corticosteroid treated pernicious anaemia. Acta med. scand. 164:159-165, 1959.
81. GRAVESON, G. S. Acute polyneuritis treated with cortisone. Lancet 272: 340-343, 1957.
82. GROB, D. & HARVEY, A. M. Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration. Bull. Johns Hopk. Hosp. 91:124-136, 1952.
83. GROB, D. & NAMBA, T. Corticotropin in generalized myasthenia gravis. J. Amer. med. Ass. 198:703-707, 1966.
84. HALVORSEN, S. Effects of ACTH on erythropoiesis in rabbit. Acta physiol. scand. 58:30-39, 1963.
85. HARTER, J. G., REDDY, J. & THORN, G. W. Studies of intermittent corticosteroid dosage regime. New Engl. J. Med. 269:591-596, 1963.
86. HEITMANN, R. & MANNWEILER, K. Tierexperimentelle Untersuchungen über die allergische Polyneuritis. Dtsch. Z. Nervenheilk. 177:28-47, 1957.
87. HERBERT, P. H. & VRIES, J. A. The administration of adrenocorticotrophic hormone to normal human subjects. The effect of leucocytes in blood and on circulating antibody levels. Endocrinology 44:259-273, 1949.
88. HOCKADAY, J. M. & SMITH, H. M. V. Corticosteroids as an adjuvant to the chemotherapy of tuberculous meningitis. Tubercle (London) 47:75-91, 1966.
89. HOECK, von E. Physiotherapie und ACTH-Behandlung bei Multipler Sklerose. Munch, med. Wschr. 105:1683-1688, 1963.
90. HOEFER, P. F. A.; ARANOW Jr.. H. & ROWLAND, L. P. Therapy of myasthenia gravis. Neurology 3:691-697, 1953.
91. HOWARD Jr., F. M. Treatment of myasthenia gravis and other diseases with a defect in neuromuscular transmission. Mod. Treatment 3:278-297, 1966.
92. HOWARD, Jr., F. M. & MULDER, D. W. Treatment of myasthenia gravis. InCurrent therapy. H. F. Conn, editor. W. B. Saunders, Philadelphia, 1964, pág. 534.
93. HYLAND, H.; WATTS, G. O. & FARGUHARSON, R. F. The course of subacute combined degeneration of the spinal cord. Canad. med. Ass. J. 65:295-302, 1951.
94. JACKSON, R. H.; MILLER, H. & SCHAPIRA, K. Polyradiculitis (Landry-Guillain-Barré syndrome). Treatment with cortisone and corticotropin. Brit, med. J. 1:480-484, 1957.
95. JAKLITSCH, H. Über die Therapie mit Hormonen in der Neurologie und Psychiatrie. Med. Klin. 53:1994-1997, 1958.
96. JERVIS, G. A.; FERRARO, A. & KOPELOFF, L. Neuropathological changes in experimental anaphylaxis in the monkeys. Arch. Neurol. Psychiat. (Chicago) 45:733-751, 1941.
97. JOHNSON, J. R. & DAVEY, W. N. Cortisone, corticotropin and antimicrobial therapy in tuberculosis in animals and man: review. Amer. Rev. Tuberc. 70:623-636, 1954.
98. JOHNSON, J. R.; FURSTENBERG, N. F.; PATTERSON, R.; SCHOCH, H. K. & DAVEY, W. N. Corticotropin and adrenal steroids as adjuvants to treatment of tuberculous meningitis. Ann. intern. Med. 46:316-331, 1957.
99. JULIAO, O. F. & MELARAGNO Filho, R. Tratamento da coréia de Sydenham pelo ACTH. Rev. Hosp. Clin. Cniv. Săo Paulo 9:279-288, 1954.
100. KABAT, E. A., WOLF, A. & BEZER, A. E. Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys: The effect of cortisone. J. Immunol. 68:265-275, 1952.
101. KABAT, E. A., WOLF, A. & BEZER, A. E. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J. exp. Med. 85:117-130, 1947.
102. KANE, C. A. The effect of certain endocrine glands on myasthenia gravis. Amer. J. Med. 24:729-733, 1955.
103. KASS, E. H. & FINLAND, M. Adrenocortical hormones and management of infectious. Ann. Rev. Med. 8:1-18, 1957.
104. KASS, E. H. & FINLAND, M. Role of adrenal steroids in infection and immunity. New Engl. J. Med. 244:464-470, 1951.
105. KENDIG Jr., E. L.; CHOY, S. H. & JOHNSON, W. H. Observations on the effect of cortisone in the treatment of tuberculous meningitis. Amer. Rev. Tuberc. 73:99-109, 1956.
106. KIBLER, R. F. Large dose corticosteroid therapy of experimental and human demyelinating diseases. Ann. N. Y. Acad. Sci.: 122:469-479, 1965.
107. KRISTENSEN, H. P. O. & FRIIS, R. Effect of prednisone on B_]2 absorption in pernicious anaemia. Acta med. scand. 166:249-254, 1960.
108. LILJESTRAND, A. & MATELL, G. Results with ACTH and spironolactone in severe cases of myasthenia gravis. Acta neurol. scand. Supl. 13:463-471, 1965.
109. LIVINGSTONE, J. L. & DA VIES, J. P. Steroids in long-term treatment of asthma. Lancet 1:1310-1314, 1961.
110. LOW, N. L. Infantile spasms with mental retardation. Treatment with cortisone and adrenocorticotropin. Pediatrics 22:1165-1169, 1958.
111. LOW, N. L., BOSNA, J. F., ARMSTRONG, M. D. & MADSEN, J. A. Infantile spasms with mental retardation. Clinical observations and dietary experiments. Pediatrics 22:1153-1164, 1958.
112. LUZES, P. M. & DIOGO-FURTADO, M. Syndrome de Guillain-Barré: quatre cas traites par l'ACTH et la cortisone. Rev. neurol. (Paris) 90:132-133, 1954.
113. McALPINE, D. The benign form of multiple sclerosis: results of a long-term study. Brit. med. J. 2:1029-1032, 1964.
114. MARQUEZY, R. A.; BACK, C. & SCHAEFFER, P. Corticothérapie et meningite tuberculeuse. Sem. Hop. Paris 33:3286-3301, 1957.
115. MARTIN, J. J. & PHILIPPART, M. Ungewőhnliche Verlaufsformen der Polyradiculoneuritis mit Liquordissoziation (Typ Guillain-Barré). Rezidivie-rende und chronische Formen. Kritische Bewertung der Kortikosteroidtherapie. Wld. Neurol. 5:409-430, 1962.
116. MASSEL, B. F.; PLACE, E. H.; STURGIS, G. P.; PRIZER, M.; KNOBLOCH, J. D. & SHIN-MAN, C. Effect of ACTH on the antistreptolysine O and gamma globulin response to hemolytic streptococcal infection (scarlet fever) and on the development of post-streptococcal sequelae. InProceedings II ACTH Clin. Conf. Vol. 1. Blakiston, New York, 1950, pag. 486.
117. MERRITT, H. H. Corticotropin and cortisone in diseases of the nervous system. Yale J. Biol. Med. 24:466-473, 1952.
118. MILLER, H. G. Acute disseminated encephalomyelitis treated with ACTH. Brit. med. J. 1:177-183, 1953.
119. MILLER, H. G. & GIBBONS, J. L. Acute disseminated encephalomyelitis and acute disseminated sclerosis. Results of treatment with ACTH. Brit, med. J. 2:1345-1348, 1953.
120. MILLER, H. G.; NEWELL, D. J. & RIDLEY, A. Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (ACTH). Lancet 2: 1120-1122, 1961.
121. MILLER, H. G.; NEWELL, D. J. & RIDLEY, A. Multiple sclerosis. Trials of maintenance treatment with prednisolone and soluble aspirin. Lancet 1:127-129, 1961.
122. MILLICHARP, J. G. Treatment of convulsive disorders, including febrile seizures, in children. Mod. Treatment 1:1087-1103, 1964.
123. MILLIKAN, C. H. & EATON, L. M. Clinical evaluation of ACTH and cortisone in myasthenia gravis. Neurology 1:145-152, 1951.
124. MORGAN, I. M. Allergic encephalomyelitis in monkeys in response to injection of normal monkey nervous tissue. J. exp. Med. 85:131-140, 1947.
125. MOUNT, F. W. Corticotropin in treatment of ocular myasthenia. Arch. Neurol. Psychiat. (Chicago) 11:114-124, 1964.
126. MOYER, A. W., JERWIS, G. A. BLAKE, J., KOPROWSKI, H. & COX, H. R. Action of adrenocorticotropic hormone (ACTH) in experimental allergic encephalomyelitis of guinea-pig. Proc. Soc. exp. Biol. 75:387-390, 1950.
127. MULDER, D. W.; WINKELMANN, R. K.; LAMBERT, E. H.; DIESSNER, G. R. & HOWARD Jr., F. N. Steroid therapy in patients with polymyositis and dermatomyositis. Ann. intern. Med. 58:969-976, 1963.
128. MÜLLER, W. & ROSWTTHA, M. Corticoidbehandlung der Neuromyelitis optica. Dtsch. Z. Nervenheilk. 185:170-182, 1963.
129. NEWEY, J. A. & LUBIN, R. I. Corticotropin (ACTH) therapy in Guillain-Barré syndrome: report of a case. J. Amer. med. Ass. 152:137-139, 1953.
130. O'DOHERTY, D. S. Treatment of the choreas. J. Neurosurg. Supl. 24: 358-359, 1966.
131. OSSERMAN, K. E. Myasthenia gravis. Grune & Stratton, New York-London, 1958.
132. OSSERMAN, K. E. Miastenia gravis: diagnóstico y tratamiento. Wid Neurol. 2:66-77, 1961.
133. OTTO, D. Die Behandlung der Multiplen Sklerose mit Corticoiden. Dtsch. Z. Nervenheilk. 185:159-169, 1963.
134. OVERMAN, J. R. & HAN AN, R. Effect of cortisone on mumps antibody formation in rabbits. Proc. Soc. exp. Biol. 82:427-430, 1953.
135. PEARSON, C. M. Treatment of polymyositis and dermatomyositis. Mod. Treatment 3:1302-1311, 1966.
136. PETTE, H. Experimental demyelinizing diseases and their implications in neurologic diseases of man. Wld Neurol. 1:491-499, 1960.
137. PLOUGH, I. C. & AYERLE, R. S. The Guillain-Barré syndrome associated with acute hepatitis. New Engl. J. Med. 249:61-62, 1953.
138. PLUM, F. Múltipla symmetrical polyneuropathy treated with cortisone. Neurology 3:661-667, 1953.
139. PAULLEY, J. W. ACTH in multiple sclerosis. Brit. med. J. 1:760-761, 1957.
140. REYS, G. von; SAHLGREN, E. & JONSSON, B. ACTH and cortisone in the treatment of multiple sclerosis. Acta psychiat. scand. 28:429-438, 1953.
141. REYS, G. von; LILGESTRAND, A. & MATELL, G. Results with ACTH and spironolactone in severe cases of myasthenia gravis. Acta neurol. scand. Supl. 13:463-471, 1965.
142. REYS, G. von; LILGESTRAND, A. & MATELL, G. Treatment of severe myasthenia gravis with large doses of ACTH. Ann. N. Y. Acad. Sci. 135:409-416, 1966.
143. RITTER, J. A. & EPSTEIN, N. Myasthenia gravis: some observations of the effects of various therapeutic agents including thymectomy and ACTH inanine-year-old child. Amer. J. med. Sci. 220:66-73, 1950.
144. RIVERS, T. M.; SPRUNT, D. H. & BERRY, G. P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. exp. Med. 58:39-53, 1933.
145. RIVERS, T. M. & SCHWENKER, F. F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. exp. Med. 61:689-702, 1935.
146. ROGER, H. Les syndromes neuro-anémiques. Marseille méd. 91:473-490, 1954.
147. ROMANSKY, M. J. Steroid therapy in systemic infections. J. Amer. med. Ass. 170:1179-1183, 1959.
148. RUSSI, F.; ROSSI, G. & BONANZA, R. La terapia delia meningite tubercolare dell'adulto del 1947 al 1957. Minerva med. (Torino) 50:606-618, 1959.
149. SCHAR, von J. Erhahrungen mit ACTH. Behandlung bei Multiple Sklerose. Schweiz. med. Wschr. 95:1289-1296, 1965.
150. SCHLEZINGER, N. S. Present status of therapy in myasthenia gravis. J. Amer. med. Ass. 148:508-513, 1952.
151. SCHUMACHER, G. A. Multiple sclerosis. Arch. Neurol. Psychiat. (Chicago) 14:571-573, 1966.
152. SCHWARTZMAN, J.; ZAONTZ, J. B. & LUBOW, H. Chorea minor. Preliminary report in six patients treated with combined ACTH and cortisone. J. Pediat. 43:278-289, 1953.
153. SCHWIND, F. Corticoidbehandlung der Polyneuritis. Dtsch. Z. Nervenheilk. 185:150-158, 1963.
154. SELLING, B. W. & MEILMAN, E. Acute disseminated encephalomyelitis treated with ACTH. Report of a case. New Engl. J. Med. 253:275-279, 1955.
155. SELTZER, H. S.; LICHTY, D. E. & CONN, J. W. Case of Guillain Barré syndrome with apparent response to ACTH. Univ. Mich. med. Bull. 18:27-31, 1952.
156. SHANE, S. J. & RILEY, C. Tuberculous meningitis; combined therapy with cortisone and antimicrobial agents. New Engl. J. Med. 249:829-834, 1953.
157. SHANE, S. J.; CLOWATER, R. A. & RILEY, C. Treatment of tuberculous meningitis with cortisone and streptomycin. Canad. med. Ass. J. 67:13-15, 1952.
158. SHY, G. M. & McEACHERN, D. Further studies of the effects of cortisone and ACTH on neurological disorders. Brain 74:354-362, 1951.
160. SIQUEIRA, L. C. & OLIVEIRA, A. Tratamento da coréia de Sydenham pelos esteróides a curto prazo. Bol. Inst. Puericult. Univ. Brasil 22:113-116, 1965.
161. SMITH, J. K. & ROSS, L. Steroid suppression of meningeal inflammation caused by pantopaque. Neurology 9:48-52, 1959.
162. SOREL, L. & DESAUCY-BAULOYE, A. A propôs de 21 cas d'hypsarythmie de Gibbs; son traitement spectaculaire par l'ACTH. Acta neurol. psychiat. belg. 58:130-141, 1958.
163. SPINA-FRANÇA, A. Cisticercose do sistema nervoso central. Consideraçőes sobre 50 casos. Rev. paulista Med. 48 : 59-70, 1956.
164. STMPS, F. W.; GIBBS, E. L.; ROSENTHAL, I. M. & GIBBS, F. A. Treatment of hypsarthythmia with ACTH. J. Amer. med. Ass. 171:408-411, 1959.
165. STILLMAN, J. S. & GANONG, W. F. The Guillain-Barré syndrome: report of a case treated with ACTH and cortisone. New Engl. J. Med. 246:293-296, 1952.
166. THIELE, R. M. Die Anwendung von Corticosteroiden in der Neurologic Fortschr. Neurol. 28:627-645, 1960.
167. THORN, G. W. Clinical considerations in the use of corticosteroids. New Engl. J. Med. 274:775-781, 1966.
168. THYGESEN, P. & FOG, M. ACTH-Cortisone treatment of disseminated sclerosis. Acta psychiat. scand. 31:169-170, 1956.
169. TORDA, C. & WOLFF, H. G. Effects of adrenocorticotrophic hormone on neuro-museular function in patients with myasthenia gravis. Proc. Soc. exp. Biol. 71:432-435, 1949.
170. TORDA, C. & WOLFF, H. G. Effects of administration of the adrenocorticotropic hormone on patients with myasthenia gravis. Arch. Neurol. Psychiat. (Chicago) 66:163-170, 1951.
171. TORDA, C. & WOLFF, H. G. Effect of adrenocorticotrophic hormone of pituitary gland on ability of tissue to synthesize acethyl-choline. Proc. Soc. exp. Biol. 57:137-139, 1944.
172. TORDA, C. & WOLFF, H. G. Effects of adrenocorticotrophic hormone on neuromuscular function in patients with myasthenia gravis. J. clin. Invest. 28:1228-1235, 1949.
173. TORDA, C. & WOLFF, H. G. Effect of blood serum from patients with myasthenia gravis on the synthesis of acetylcholine in vitro. J. clin. Invest. 23:649-656, 1944.
174. TORDA, C. & WOLFF, H. G. Effects of hypophysectomy and adrenocorticotrophic hormone on neuromuscular function and acetylcholine synthesis. Amer. J. Physiol. 161:534-539, 1950.
175. TRELLES, J. O. Cerebral cysticercosis. Wld Neurol. 2:488-497, 1961.
176. VICTOR, M. & LEAR, A. A. Subacute combined degeneration of the spinal cord. Current concepts of the disease process. Value of serum vitamin B₁₂determinations in clarifying some of the common clinical problems. Amer. J. Med. 20:896-911, 1956.
177. ZIEGLER, D. K. Acute disseminated encephalitis. Some therapeutic and diagnostic considerations. Arch. Neurol. Psychiat. (Chicago) 14:476-488, 1966.
178. WAHREN, W. über Cortisonbehandlung bei einigen Erregerkrankheiten des Nervensystems. Dtsch. Z. Nervenheilk. 185:183-190, 1963.
179. WALLACE, T. W. & WILLIAMS, G. H. Jr. ACTH in acute neurologic disorders. Neurology 11:91-95, 1961.
180. WALTON, J. N. & ADAMS, R. D. Polymyositis. E. & S. Livingston. Ltd., Edinburg, 1958, pp. 289.
181. WASZ-HOCKERT, O. Modern treatment and late prognosis of tuberculous meningitis. Acta paediat. (Stocolmo), 51, supl. 141, pp. 93, 1962.
182. WHITE, J. C; SWEET, W. H. & RICHARDSON, E. P. Cysticercosis cerebri: A diagnostic and therapeutic problem in increasing importance. New Engl. J. Med. 256:479-486, 1957.

Datas de Publicação

Publicação nesta coleção
13 Maio 2013
Data do Fascículo
Dez 1968

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

[1] 1. AINGER, L. E.; ELY, R. S.; DONE, A. K. & KELLY, V. C. Sydenham's chorea. Effects of hormonetherapy. Amer. J. Dis. Child. 89:580-590, 1955.

[2] 2. ALAJOUANINE, Th.; CASTAIGNE, P. & LHERMITTE, F. A propos du traitement de la esclérose en plaques par la cortisone. Rev. neurol. (Paris) 94:352, 1956.

[3] 3. ALBERNAZ, J. G. & CARMO, R. J. Terapęutica hormonal na coréia de Sydenham. Arq. Neuro-Psiquiat. (Săo Paulo) 15:204-210, 1957.

[4] 4. ALEXANDER, L.; CASS, L. J.; ENDERS, M. & SARAI, K. Adrenocortical response to high dosage ACTH therapy in patients with multiple sclerosis. Confin. neurol. (Basel) 28:1-17, 1966.

[5] 5. ALEXANDER, L.; BERKELEY, A. W. & ALEXANDER, A. M. Prognosis and treatment of multiple sclerosis Quantitative nosometric study. J. Amer. med. Ass. 166:1943-1949, 1958.

[6] 6. ALEXANDER, L. & CASS, L. J. The present status of ACTH Therapy in multiple sclerosis. Ann. intern. Med. 58:454-471, 1963.

[7] 7. ALLEN, J. E. Treatment of measles encephalitis with adrenal steroids. Pediatrics 20:87-91, 1957.

[8] 8. ARONSON, N.; DOUGLAS, H. S. & LEWIS, J. M. Cortisone in Sydenham's chorea: report of 2 cases. J. Amer. med. Ass. 145:30-33, 1951.

[9] 9. ARROBA, C. V. Tratamientos de la miastenia gravis. Rev. clin. esp. 82: 195-199, 1961.

[10] 10. ASHBY, M. & GRANT, H. Tuberculous meningitis treated with cortisone. Lancet 1:65-66, 1955.

[11] 11. ASSIS, J. L. Síndrome de Guillain-Barré. A propósito de tręs casos, sendo um tratado pelo ACTH. Arq. Neuro-Psiquiat. (Săo Paulo) 10:133-134, 1952.

[12] 12. ASSIS, J. L. Encefalopatía reumática tratada pelo ACTH e cortisona. Rev. paulista Med. 44:322-326, 1954.

[13] 13. ASSIS, J. L. A terapęutica química e biológica atual da meningocefalite tuberculosa difusa. Rev. paulista Med. 48:80-89, 1956.

[14] 14. ASSIS, J. L. Tratamento dos casos graves de miastenia. Açăo do ACTH e cortisona. Consideraçőes a propósito de tręs casos. Arq. Neuro-Psiquiat. (Săo Paulo) 14:28-36, 1956.

[15] 15. ASSIS, J. L. Tratamento das formas severas de miastenia grave pelo ACTH por via intravenosa. Arq. Neuro-Psiquiat. (Săo Paulo) 18:359-382, 1960.

[16] 16. ASSIS, J. L. Tratamento atual da miastenia grave. Rev. paulista Med. 67:231-242, 1965.

[17] 17. ASSIS, J. L. Moléstias desmielinizantes. InManual de Clínica Neurológica, H. Canelas, editor. Sarvier, Săo Paulo, 1967, pp. 105-117.

[18] 18. ASSIS, J. L. Neurotuberculose. InManual de Clínica Neurológica, H. M. Canelas, editor. Sarvier, Săo Paulo, 1967, pp. 229-236.

[19] 19. ASSIS, J. L. Miastenia grave. InManual de Clínica Neurológica, H. M. Canelas, editor. Sarvier, Săo Paulo, 1967, pp. 339-347.

[20] 20. ASSIS, J. L. & SPINA-FRANÇA, A. Síndrome de Güillain-Barré. A propósito de cinco casos tratados com ACTH e cortisona. Arq. Neuro-Psiquiat. (Săo Paulo) 11:414-419, 1953.

[21] 21. ASSIS, J. L. & DUCHĘNE, G. H. Complicaçőes neurológicas da vacinaçăo anti-rábica. Arq. Neuro-Psiquiat. (Săo Paulo) 17:235-250, 1959.

[22] 22. AUSTIN, J. H. Recurrent polyneuropathies and their corticosteroid treatment with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone. Brain 81:157-192, 1958.

[23] 23. BAMMER, H. ACTH und Corticoidbehandlung neurologischer Krankheiten. Dtsch. Z. Nervenheilk. 185:121-149, 1963.

[24] 24. BASTRUP-MADSEN, P. Non-anaemic neuropathy due to deficiency of anti-pernicious anaemia principle. Acta psychiat. neurol. scand. Supl. 108:45-36, 1956.

[25] 25. BARNICK, D. D. & WALTON, J. M. Polymiositis. Amer. J. Med. 35: 646-660, 1963.

[26] 26. BAUMANN, J. Results of treatment of certain diseases of the central nervous system with ACTH and corticosteroids. Acta neurol. scand. Supl. 13:453-461, 1965.

[27] 27. BERG, J. M. Complications neurologiques de la coqueluche. Wld Neurol. 2:56-65, 1961.

[28] 28. BERLACHER, F. J. & ALBINGTON, R. B. ACTH and cortisone in Guillain-Barré syndrome: review of the literature and report of a treated case following primary atypical pneumonia. Ann. intern. Med. 48:1106-1118, 1958.

[29] 29. BLOMBERG. L. H. Comments on treatment of multiple sclerosis with ACTH. Acta neurol. scand. Supl. 13:485-487, 1965.

[30] 30. BLOOD, A.; LOCKE, W. & CARAHASI, R. Guillain-Barré syndrome treated with corticotropin (ACTH). J. Amer. med. Ass. 152:139-140, 1953.

[31] 31. BOGAERT, L. van; RADERMECKER, M. A.; LOWENTHAL, A. & KETELAER, C. J. Les polymyosites chroniques (Essais avec la cortisone). Acta neurol. psychiat. belg. 55:869-922, 1965.

[32] 32. BOWER, B. D. & JEAVONS. P. M. Infantile spasms and hypsarrhythmia. Lancet 1:605-609, 1959.

[33] 33. BRANDRIN, M. W.; SMITH, J. W. & FRIEDMAN, R. M. Supression of experimental allergic encephalomyelitis by antimetabolites. Ann. N. Y. Acad. Sci. 122:356-368, 1965.

[34] 34. BRIGGS, G. W. & BROWN, W. M. Neurological complications of antirabies vaccine. Treatment with corticosteroids. J. Amer. med. Ass. 173:802-804, 1960.

[35] 35. BROOKS, W. D. W.; FLETCHER, A. P. & WILSON, R. R. Spinal cord complications of tuberculous meningitis. Quart. J. Med. 23:275-290, 1954.

[36] 36. CANELAS, H. M. Distúrbios neurológicos nos estados carenciais aqúilicos, Arq. Neuro-Psiquiat. (Săo Paulo) 10:1-40, 1952.

[37] 37. CANELAS, H. M. Mieloses funiculares: consideraçőes a propósito de 110 casos. Arq. Neuro-Psiquiat. (Săo Paulo) 18:105-132, 1960.

[38] 38. CANELAS. H. M. Corticotrofina e corticosteróides em Neurologia. Rev. paulista Med. 57:301-313, 1960.

[39] 39. CANELAS, H. M. Neurocisticercose: incidęncia, diagnóstico e formas clínicas. Arq. Neuro-Psiquiat. (Săo Paulo) 20:1-16, 1962.

[40] 40. CANELAS, H. M. & LEVY, J. A. Resultados preliminares do emprego do ACTH nas degeneraçőes combinadas da medula. Arq. Neuro-Psiquiat. (Săo Paulo) 11:253-258, 1953.

[41] 41. CANELAS, H. M. & SPINA-FRANÇA, A. ACTH e cortisona em Neurologia. Resultados em 23 casos. Rev. paulista Med. 43:115-120, 1953.

[42] 42. CANELAS, H. M.; CARVALHO, N. & ROCHA, A. G. Effect of corticotropin on the absorption of vitamina B¹² in sub-acute combined degeneration of the spinal cord. Arq. Neuro-Psiquiat. (Săo Paulo) 23:75-81, 1965.

[43] 43. CASS, L. J.; ALEXANDER, L. & ENDERS, M. Complications of corticotropin therapy in multiple sclerosis. J. Amer. med. Ass. 197:173-210, 1966.

[44] 44. CLARKE, E.; BAYLISS, R. I. S. & COOPER, R. Landry-Guillain-Barré syndrome: cardiovascular complications. Treatment with ACTH and cortisone. Brit. med. J. 2:1504-1507, 1954.

[45] 45. CROZIER, R. E. & AINLEY, A. B. The Guillain-Barré syndrome. New Engl. J. Med. 252:83-88, 1955.

[46] 46. CUNNINGHAM, V. R. & FIELD, E. J. Experimental allergic encephalomyelitis: protection experiments with encephalitogenic factor and tubercle fraction. Ann. N. Y. Acad. Sci. 122:346-355, 1965.

[47] 47. DANILSEN, J. Infantile spasms and hypsarhythmia treated with corticosteroids. Acta neurol. scand. Supl. 13:489-492, 1965.

[48] 48. DE JONG, R. N. The Guillain-Barré syndrome. Polyradiculoneuritis with albuminocytologic dissociation. Arch. Neurol. Psychiat. (Chicago) 44:1044-1068, 1940.

[49] 49. DESTAIGNE, F. La corticothérapie dans les maladies infectieuses. Rev. méd. Dijon 2:251-256, 1967.

[50] 50. DIESSNER, G. R. & WINKELMANN, R. K. Treatment of polymyositis. Mod. Treatment 3:304-312, 1966.

[51] 51. DOBBS, J. M.; CLEMENTS, J. D. & BAIRD, H. W. Treatment of infantile myoclonic seizures with corticotropin and corticosteroid. Amer. J. Dis. Child. 98:524-525, 1959.

[52] 52. DOERNER, A. A.; NAEGELE, C. F. & REGAN, F. D. Development of tuberculous meningitis following cortisone therapy. Amer. Rev. Tuberc. 64: 564-571. 1951.

[53] 53. DRENICK, E. J. & AVOL, M. Two cases of Guillain-Barré syndrome treated with cortisone. Neurology 3:935-938, 1953.

[54] 54. EATON, L. M. The perspective of neurology in regard to polymyositis. A study of 41 cases. Neurology 4:245-263, 1954.

[55] 55. FELDMAN, S. Clinical observations on the value of adrenocortical therapy in the Guillain-Barré syndrome. Confín, neurol. (Basel) 26:76-88, 1965.

[56] 56. FELDMAN, S.; BEHAR, J. A. & SAMUELOFF, M. Effect of cortisone and hydrocortisone on piarachnoid adhesions; experimental study. Arch. Neurol. Psychiat. (Chicago) 74:681-688, 1955.

[57] 57. FERRARO, A. Studies on multiple sclerosis. J. Neuropath. 17:278-297, 1958.

[58] 58. FERRARO, A. & CAZZULLO, C. L. Chronic experimental allergic encephalomyelitis in monkeys. J. Neuropath. 7:235-260, 1948.

[59] 59. FERRARO, A. & JERVIS, G. A. Experimental disseminated encephalopathy in the monkey. Arch. Neurol. Psychiat. (Chicago) 43:195-209, 1940.

[60] 60. FERRARO, A. & ROIZIN, L. Experimental allergic encephalomyelitis during and following cortone acetate treatment. J. Neuropath. 12:373-386, 1953.

[61] 61. FERRARO, A. & ROIZIN, L. Hyperergic encephalomyelitis following exanthematic diseases, infectious diseases and vaccination. J. Neuropath. 16: 423-445, 1957.

[62] 62. FERRARO, A.; ROIZIN, L. & CAZZULLO, C. L. Experimental studies in allergic encephalomyelitis. J. Neuropath. 9:18-28, 1950.

[63] 63. FÍESE, M. J.; CHEY, S. & RADDING, J. Guillain-Barré syndrome in infectious mononucleosis. Report of case with recovery following administration of cortisone. Arch, inter. Med. 92:438-441, 1953.

[64] 64. FINLAND, M.; KASS, E. H. & INGBAR, S. H. Further observations on the effects of ACTH in acute infections. InProceedings, II ACTH Clin. Conf. Vol. 1. Blakiston, New York, 1950, pág. 478.

[65] 65. FISCH, A. M.; OLIVEIRA, C. & FERNANDES, I. Contribuiçăo ao estudo da hipsarritmia. Arq. Neuro-Psiquiat. (Săo Paulo) 24:15-27, 1966.

[66] 66. FOG, T. Some experiences with ACTH. Treatment in disseminated sclerosis. Acta endocr. 9:213-257, 1952.

[67] 67. FOSTER, J. B. The use of adrenal steroids in diseases of the nervous system. In Modern Trends in Neurology. D. Williams, editor. Butterworths, London, pp. 292-313, 1962.

[68] 68. FOT, T. The long-term treatment of multiple sclerosis with corticoids. Acta neurol. scand. Supl. 13:473-484, 1965.

[69] 69. FREIDBERG, L. D. The place of corticotropin in the treatment of myastenia gravis. Ann. intern. Med. 52:806-818, 1960.

[70] 70. FREUND, J. & McDERMOTT Sensitization to horse serum by means of adjuvants. Proc. Soc. exp. Biol. (New York) 49:548-553, 1942.

[71] 71. FREUND, J.; STERN, E. R. & PISANI, T. M. Isoallergic encephalomyelitis and radiculitis in guinea-pigs after one injection of brain and mycobacteria in water-in-oil emulsion. J. Immunol. 57:179-194, 1947.

[72] 72. FROST, J. W. & GOLDWEIN, M. I. Observation on vitamina B¹² absorption in primary pernicious anemia during administration of adrenocortical steroids. New Engl. J. Med. 258:1096-1098, 1958.

[73] 73. FROST, J. W. GOLDWEIN, M. I. & KAUGMAN, B. D. Studies of B₁₂ Co⁶⁰ absorption in malabsorption syndrome: results before and during specific therapy. Ann intern. Med. 47:293-299, 1957.

[74] 74. GAMMON, G. A. & DILWORTH, M. J. Effect of corticotropin on paralysis of experimental allergic encephalomyelitis. Arch. Neurol. Psychiat. (Chicago) 69:649, 1953.

[75] 75. GLASER, G. H. Les cortico-stéroides et l'ACTH dans les affections nerveuses. Wld Neurol. 1:12-21, 1960.

[76] 76. GLASER, G. H. & MERRITT, H. H. Effects of corticotropin (ACTH) and cortisone on disorders of the nervous system. J. Amer. med. Ass. 148: 898-904, 1952.

[77] 77. GLASS, G. B. J. Biochemistry and physiology of Castle's intrinsic factor and its relationship to the metabolism of vitamin B₁₂ Rev. Hémat. 10: 137-179, 1955.

[78] 78. GLASS, G. B. J. Intestinal absorption and hepatic uptake of vitamina B_]2in diseases of the gastrointestinal tract. Gastroenterology 30:37-52, 1956.

[79] 79. GLASS, G. B. J. Gastric intrinsic factor and its function in the metabolism of vitamin B₁₂ Physiol. Rev. 43:529-849, 1963.

[80] 80. GORDIN, R. Vitamin B₁₂ absorption in corticosteroid treated pernicious anaemia. Acta med. scand. 164:159-165, 1959.

[81] 81. GRAVESON, G. S. Acute polyneuritis treated with cortisone. Lancet 272: 340-343, 1957.

[82] 82. GROB, D. & HARVEY, A. M. Effect of adrenocorticotropic hormone (ACTH) and cortisone administration in patients with myasthenia gravis and report of onset of myasthenia gravis during prolonged cortisone administration. Bull. Johns Hopk. Hosp. 91:124-136, 1952.

[83] 83. GROB, D. & NAMBA, T. Corticotropin in generalized myasthenia gravis. J. Amer. med. Ass. 198:703-707, 1966.

[84] 84. HALVORSEN, S. Effects of ACTH on erythropoiesis in rabbit. Acta physiol. scand. 58:30-39, 1963.

[85] 85. HARTER, J. G., REDDY, J. & THORN, G. W. Studies of intermittent corticosteroid dosage regime. New Engl. J. Med. 269:591-596, 1963.

[86] 86. HEITMANN, R. & MANNWEILER, K. Tierexperimentelle Untersuchungen über die allergische Polyneuritis. Dtsch. Z. Nervenheilk. 177:28-47, 1957.

[87] 87. HERBERT, P. H. & VRIES, J. A. The administration of adrenocorticotrophic hormone to normal human subjects. The effect of leucocytes in blood and on circulating antibody levels. Endocrinology 44:259-273, 1949.

[88] 88. HOCKADAY, J. M. & SMITH, H. M. V. Corticosteroids as an adjuvant to the chemotherapy of tuberculous meningitis. Tubercle (London) 47:75-91, 1966.

[89] 89. HOECK, von E. Physiotherapie und ACTH-Behandlung bei Multipler Sklerose. Munch, med. Wschr. 105:1683-1688, 1963.

[90] 90. HOEFER, P. F. A.; ARANOW Jr.. H. & ROWLAND, L. P. Therapy of myasthenia gravis. Neurology 3:691-697, 1953.

[91] 91. HOWARD Jr., F. M. Treatment of myasthenia gravis and other diseases with a defect in neuromuscular transmission. Mod. Treatment 3:278-297, 1966.

[92] 92. HOWARD, Jr., F. M. & MULDER, D. W. Treatment of myasthenia gravis. InCurrent therapy. H. F. Conn, editor. W. B. Saunders, Philadelphia, 1964, pág. 534.

[93] 93. HYLAND, H.; WATTS, G. O. & FARGUHARSON, R. F. The course of subacute combined degeneration of the spinal cord. Canad. med. Ass. J. 65:295-302, 1951.

[94] 94. JACKSON, R. H.; MILLER, H. & SCHAPIRA, K. Polyradiculitis (Landry-Guillain-Barré syndrome). Treatment with cortisone and corticotropin. Brit, med. J. 1:480-484, 1957.

[95] 95. JAKLITSCH, H. Über die Therapie mit Hormonen in der Neurologie und Psychiatrie. Med. Klin. 53:1994-1997, 1958.

[96] 96. JERVIS, G. A.; FERRARO, A. & KOPELOFF, L. Neuropathological changes in experimental anaphylaxis in the monkeys. Arch. Neurol. Psychiat. (Chicago) 45:733-751, 1941.

[97] 97. JOHNSON, J. R. & DAVEY, W. N. Cortisone, corticotropin and antimicrobial therapy in tuberculosis in animals and man: review. Amer. Rev. Tuberc. 70:623-636, 1954.

[98] 98. JOHNSON, J. R.; FURSTENBERG, N. F.; PATTERSON, R.; SCHOCH, H. K. & DAVEY, W. N. Corticotropin and adrenal steroids as adjuvants to treatment of tuberculous meningitis. Ann. intern. Med. 46:316-331, 1957.

[99] 99. JULIAO, O. F. & MELARAGNO Filho, R. Tratamento da coréia de Sydenham pelo ACTH. Rev. Hosp. Clin. Cniv. Săo Paulo 9:279-288, 1954.

[100] 100. KABAT, E. A., WOLF, A. & BEZER, A. E. Studies on acute disseminated encephalomyelitis produced experimentally in rhesus monkeys: The effect of cortisone. J. Immunol. 68:265-275, 1952.

[101] 101. KABAT, E. A., WOLF, A. & BEZER, A. E. The rapid production of acute disseminated encephalomyelitis in rhesus monkeys by injection of heterologous and homologous brain tissue with adjuvants. J. exp. Med. 85:117-130, 1947.

[102] 102. KANE, C. A. The effect of certain endocrine glands on myasthenia gravis. Amer. J. Med. 24:729-733, 1955.

[103] 103. KASS, E. H. & FINLAND, M. Adrenocortical hormones and management of infectious. Ann. Rev. Med. 8:1-18, 1957.

[104] 104. KASS, E. H. & FINLAND, M. Role of adrenal steroids in infection and immunity. New Engl. J. Med. 244:464-470, 1951.

[105] 105. KENDIG Jr., E. L.; CHOY, S. H. & JOHNSON, W. H. Observations on the effect of cortisone in the treatment of tuberculous meningitis. Amer. Rev. Tuberc. 73:99-109, 1956.

[106] 106. KIBLER, R. F. Large dose corticosteroid therapy of experimental and human demyelinating diseases. Ann. N. Y. Acad. Sci.: 122:469-479, 1965.

[107] 107. KRISTENSEN, H. P. O. & FRIIS, R. Effect of prednisone on B_]2 absorption in pernicious anaemia. Acta med. scand. 166:249-254, 1960.

[108] 108. LILJESTRAND, A. & MATELL, G. Results with ACTH and spironolactone in severe cases of myasthenia gravis. Acta neurol. scand. Supl. 13:463-471, 1965.

[109] 109. LIVINGSTONE, J. L. & DA VIES, J. P. Steroids in long-term treatment of asthma. Lancet 1:1310-1314, 1961.

[110] 110. LOW, N. L. Infantile spasms with mental retardation. Treatment with cortisone and adrenocorticotropin. Pediatrics 22:1165-1169, 1958.

[111] 111. LOW, N. L., BOSNA, J. F., ARMSTRONG, M. D. & MADSEN, J. A. Infantile spasms with mental retardation. Clinical observations and dietary experiments. Pediatrics 22:1153-1164, 1958.

[112] 112. LUZES, P. M. & DIOGO-FURTADO, M. Syndrome de Guillain-Barré: quatre cas traites par l'ACTH et la cortisone. Rev. neurol. (Paris) 90:132-133, 1954.

[113] 113. McALPINE, D. The benign form of multiple sclerosis: results of a long-term study. Brit. med. J. 2:1029-1032, 1964.

[114] 114. MARQUEZY, R. A.; BACK, C. & SCHAEFFER, P. Corticothérapie et meningite tuberculeuse. Sem. Hop. Paris 33:3286-3301, 1957.

[115] 115. MARTIN, J. J. & PHILIPPART, M. Ungewőhnliche Verlaufsformen der Polyradiculoneuritis mit Liquordissoziation (Typ Guillain-Barré). Rezidivie-rende und chronische Formen. Kritische Bewertung der Kortikosteroidtherapie. Wld. Neurol. 5:409-430, 1962.

[116] 116. MASSEL, B. F.; PLACE, E. H.; STURGIS, G. P.; PRIZER, M.; KNOBLOCH, J. D. & SHIN-MAN, C. Effect of ACTH on the antistreptolysine O and gamma globulin response to hemolytic streptococcal infection (scarlet fever) and on the development of post-streptococcal sequelae. InProceedings II ACTH Clin. Conf. Vol. 1. Blakiston, New York, 1950, pag. 486.

[117] 117. MERRITT, H. H. Corticotropin and cortisone in diseases of the nervous system. Yale J. Biol. Med. 24:466-473, 1952.

[118] 118. MILLER, H. G. Acute disseminated encephalomyelitis treated with ACTH. Brit. med. J. 1:177-183, 1953.

[119] 119. MILLER, H. G. & GIBBONS, J. L. Acute disseminated encephalomyelitis and acute disseminated sclerosis. Results of treatment with ACTH. Brit, med. J. 2:1345-1348, 1953.

[120] 120. MILLER, H. G.; NEWELL, D. J. & RIDLEY, A. Multiple sclerosis. Treatment of acute exacerbations with corticotrophin (ACTH). Lancet 2: 1120-1122, 1961.

[121] 121. MILLER, H. G.; NEWELL, D. J. & RIDLEY, A. Multiple sclerosis. Trials of maintenance treatment with prednisolone and soluble aspirin. Lancet 1:127-129, 1961.

[122] 122. MILLICHARP, J. G. Treatment of convulsive disorders, including febrile seizures, in children. Mod. Treatment 1:1087-1103, 1964.

[123] 123. MILLIKAN, C. H. & EATON, L. M. Clinical evaluation of ACTH and cortisone in myasthenia gravis. Neurology 1:145-152, 1951.

[124] 124. MORGAN, I. M. Allergic encephalomyelitis in monkeys in response to injection of normal monkey nervous tissue. J. exp. Med. 85:131-140, 1947.

[125] 125. MOUNT, F. W. Corticotropin in treatment of ocular myasthenia. Arch. Neurol. Psychiat. (Chicago) 11:114-124, 1964.

[126] 126. MOYER, A. W., JERWIS, G. A. BLAKE, J., KOPROWSKI, H. & COX, H. R. Action of adrenocorticotropic hormone (ACTH) in experimental allergic encephalomyelitis of guinea-pig. Proc. Soc. exp. Biol. 75:387-390, 1950.

[127] 127. MULDER, D. W.; WINKELMANN, R. K.; LAMBERT, E. H.; DIESSNER, G. R. & HOWARD Jr., F. N. Steroid therapy in patients with polymyositis and dermatomyositis. Ann. intern. Med. 58:969-976, 1963.

[128] 128. MÜLLER, W. & ROSWTTHA, M. Corticoidbehandlung der Neuromyelitis optica. Dtsch. Z. Nervenheilk. 185:170-182, 1963.

[129] 129. NEWEY, J. A. & LUBIN, R. I. Corticotropin (ACTH) therapy in Guillain-Barré syndrome: report of a case. J. Amer. med. Ass. 152:137-139, 1953.

[130] 130. O'DOHERTY, D. S. Treatment of the choreas. J. Neurosurg. Supl. 24: 358-359, 1966.

[131] 131. OSSERMAN, K. E. Myasthenia gravis. Grune & Stratton, New York-London, 1958.

[132] 132. OSSERMAN, K. E. Miastenia gravis: diagnóstico y tratamiento. Wid Neurol. 2:66-77, 1961.

[133] 133. OTTO, D. Die Behandlung der Multiplen Sklerose mit Corticoiden. Dtsch. Z. Nervenheilk. 185:159-169, 1963.

[134] 134. OVERMAN, J. R. & HAN AN, R. Effect of cortisone on mumps antibody formation in rabbits. Proc. Soc. exp. Biol. 82:427-430, 1953.

[135] 135. PEARSON, C. M. Treatment of polymyositis and dermatomyositis. Mod. Treatment 3:1302-1311, 1966.

[136] 136. PETTE, H. Experimental demyelinizing diseases and their implications in neurologic diseases of man. Wld Neurol. 1:491-499, 1960.

[137] 137. PLOUGH, I. C. & AYERLE, R. S. The Guillain-Barré syndrome associated with acute hepatitis. New Engl. J. Med. 249:61-62, 1953.

[138] 138. PLUM, F. Múltipla symmetrical polyneuropathy treated with cortisone. Neurology 3:661-667, 1953.

[139] 139. PAULLEY, J. W. ACTH in multiple sclerosis. Brit. med. J. 1:760-761, 1957.

[140] 140. REYS, G. von; SAHLGREN, E. & JONSSON, B. ACTH and cortisone in the treatment of multiple sclerosis. Acta psychiat. scand. 28:429-438, 1953.

[141] 141. REYS, G. von; LILGESTRAND, A. & MATELL, G. Results with ACTH and spironolactone in severe cases of myasthenia gravis. Acta neurol. scand. Supl. 13:463-471, 1965.

[142] 142. REYS, G. von; LILGESTRAND, A. & MATELL, G. Treatment of severe myasthenia gravis with large doses of ACTH. Ann. N. Y. Acad. Sci. 135:409-416, 1966.

[143] 143. RITTER, J. A. & EPSTEIN, N. Myasthenia gravis: some observations of the effects of various therapeutic agents including thymectomy and ACTH inanine-year-old child. Amer. J. med. Sci. 220:66-73, 1950.

[144] 144. RIVERS, T. M.; SPRUNT, D. H. & BERRY, G. P. Observations on attempts to produce acute disseminated encephalomyelitis in monkeys. J. exp. Med. 58:39-53, 1933.

[145] 145. RIVERS, T. M. & SCHWENKER, F. F. Encephalomyelitis accompanied by myelin destruction experimentally produced in monkeys. J. exp. Med. 61:689-702, 1935.

[146] 146. ROGER, H. Les syndromes neuro-anémiques. Marseille méd. 91:473-490, 1954.

[147] 147. ROMANSKY, M. J. Steroid therapy in systemic infections. J. Amer. med. Ass. 170:1179-1183, 1959.

[148] 148. RUSSI, F.; ROSSI, G. & BONANZA, R. La terapia delia meningite tubercolare dell'adulto del 1947 al 1957. Minerva med. (Torino) 50:606-618, 1959.

[149] 149. SCHAR, von J. Erhahrungen mit ACTH. Behandlung bei Multiple Sklerose. Schweiz. med. Wschr. 95:1289-1296, 1965.

[150] 150. SCHLEZINGER, N. S. Present status of therapy in myasthenia gravis. J. Amer. med. Ass. 148:508-513, 1952.

[151] 151. SCHUMACHER, G. A. Multiple sclerosis. Arch. Neurol. Psychiat. (Chicago) 14:571-573, 1966.

[152] 152. SCHWARTZMAN, J.; ZAONTZ, J. B. & LUBOW, H. Chorea minor. Preliminary report in six patients treated with combined ACTH and cortisone. J. Pediat. 43:278-289, 1953.

[153] 153. SCHWIND, F. Corticoidbehandlung der Polyneuritis. Dtsch. Z. Nervenheilk. 185:150-158, 1963.

[154] 154. SELLING, B. W. & MEILMAN, E. Acute disseminated encephalomyelitis treated with ACTH. Report of a case. New Engl. J. Med. 253:275-279, 1955.

[155] 155. SELTZER, H. S.; LICHTY, D. E. & CONN, J. W. Case of Guillain Barré syndrome with apparent response to ACTH. Univ. Mich. med. Bull. 18:27-31, 1952.

[156] 156. SHANE, S. J. & RILEY, C. Tuberculous meningitis; combined therapy with cortisone and antimicrobial agents. New Engl. J. Med. 249:829-834, 1953.

[157] 157. SHANE, S. J.; CLOWATER, R. A. & RILEY, C. Treatment of tuberculous meningitis with cortisone and streptomycin. Canad. med. Ass. J. 67:13-15, 1952.

[158] 158. SHY, G. M. & McEACHERN, D. Further studies of the effects of cortisone and ACTH on neurological disorders. Brain 74:354-362, 1951.

[159] 160. SIQUEIRA, L. C. & OLIVEIRA, A. Tratamento da coréia de Sydenham pelos esteróides a curto prazo. Bol. Inst. Puericult. Univ. Brasil 22:113-116, 1965.

[160] 161. SMITH, J. K. & ROSS, L. Steroid suppression of meningeal inflammation caused by pantopaque. Neurology 9:48-52, 1959.

[161] 162. SOREL, L. & DESAUCY-BAULOYE, A. A propôs de 21 cas d'hypsarythmie de Gibbs; son traitement spectaculaire par l'ACTH. Acta neurol. psychiat. belg. 58:130-141, 1958.

[162] 163. SPINA-FRANÇA, A. Cisticercose do sistema nervoso central. Consideraçőes sobre 50 casos. Rev. paulista Med. 48 : 59-70, 1956.

[163] 164. STMPS, F. W.; GIBBS, E. L.; ROSENTHAL, I. M. & GIBBS, F. A. Treatment of hypsarthythmia with ACTH. J. Amer. med. Ass. 171:408-411, 1959.

[164] 165. STILLMAN, J. S. & GANONG, W. F. The Guillain-Barré syndrome: report of a case treated with ACTH and cortisone. New Engl. J. Med. 246:293-296, 1952.

[165] 166. THIELE, R. M. Die Anwendung von Corticosteroiden in der Neurologic Fortschr. Neurol. 28:627-645, 1960.

[166] 167. THORN, G. W. Clinical considerations in the use of corticosteroids. New Engl. J. Med. 274:775-781, 1966.

[167] 168. THYGESEN, P. & FOG, M. ACTH-Cortisone treatment of disseminated sclerosis. Acta psychiat. scand. 31:169-170, 1956.

[168] 169. TORDA, C. & WOLFF, H. G. Effects of adrenocorticotrophic hormone on neuro-museular function in patients with myasthenia gravis. Proc. Soc. exp. Biol. 71:432-435, 1949.

[169] 170. TORDA, C. & WOLFF, H. G. Effects of administration of the adrenocorticotropic hormone on patients with myasthenia gravis. Arch. Neurol. Psychiat. (Chicago) 66:163-170, 1951.

[170] 171. TORDA, C. & WOLFF, H. G. Effect of adrenocorticotrophic hormone of pituitary gland on ability of tissue to synthesize acethyl-choline. Proc. Soc. exp. Biol. 57:137-139, 1944.

[171] 172. TORDA, C. & WOLFF, H. G. Effects of adrenocorticotrophic hormone on neuromuscular function in patients with myasthenia gravis. J. clin. Invest. 28:1228-1235, 1949.

[172] 173. TORDA, C. & WOLFF, H. G. Effect of blood serum from patients with myasthenia gravis on the synthesis of acetylcholine in vitro. J. clin. Invest. 23:649-656, 1944.

[173] 174. TORDA, C. & WOLFF, H. G. Effects of hypophysectomy and adrenocorticotrophic hormone on neuromuscular function and acetylcholine synthesis. Amer. J. Physiol. 161:534-539, 1950.

[174] 175. TRELLES, J. O. Cerebral cysticercosis. Wld Neurol. 2:488-497, 1961.

[175] 176. VICTOR, M. & LEAR, A. A. Subacute combined degeneration of the spinal cord. Current concepts of the disease process. Value of serum vitamin B₁₂determinations in clarifying some of the common clinical problems. Amer. J. Med. 20:896-911, 1956.

[176] 177. ZIEGLER, D. K. Acute disseminated encephalitis. Some therapeutic and diagnostic considerations. Arch. Neurol. Psychiat. (Chicago) 14:476-488, 1966.

[177] 178. WAHREN, W. über Cortisonbehandlung bei einigen Erregerkrankheiten des Nervensystems. Dtsch. Z. Nervenheilk. 185:183-190, 1963.

[178] 179. WALLACE, T. W. & WILLIAMS, G. H. Jr. ACTH in acute neurologic disorders. Neurology 11:91-95, 1961.

[179] 180. WALTON, J. N. & ADAMS, R. D. Polymyositis. E. & S. Livingston. Ltd., Edinburg, 1958, pp. 289.

[180] 181. WASZ-HOCKERT, O. Modern treatment and late prognosis of tuberculous meningitis. Acta paediat. (Stocolmo), 51, supl. 141, pp. 93, 1962.

[181] 182. WHITE, J. C; SWEET, W. H. & RICHARDSON, E. P. Cysticercosis cerebri: A diagnostic and therapeutic problem in increasing importance. New Engl. J. Med. 256:479-486, 1957.

Corticotrofina e cortiomdes em neurologia: avaliação critica dos resultados em 518 pacientes hospitalizados

Corticotropin and corticosteroids in Neurology: critical evaluation of the results in 518 patients

Resumos

Referências bibliográficas

Datas de Publicação